Identification of postmortem paliperidone metabolite in human blood by LC–Q-Orbitrap-MS

• Published in: Journal of analytical toxicology Vol. 47; no. 6; pp. 517 - 522
• Main Authors: Yamagishi, Yoshikazu, Inokuchi, Go, Hoshioka, Yumi, Nagasawa, Sayaka, Iwase, Hirotaro, Ogra, Yasumitsu
• Format: Journal Article
• Language: English
• Published: US Oxford University Press 22.07.2023
• ISSN: 0146-4760; 1945-2403; 1945-2403
• DOI: 10.1093/jat/bkad033

Abstract Paliperidone is a widely used antipsychotic agent detected in many fatal intoxications and suicide cases. In forensic toxicology, the accurate determination of blood paliperidone concentrations is required to prove death by paliperidone poisoning. However, the lethal concentration of paliperidone in blood at autopsy differs from that at the time of death. In this study, we found that paliperidone was decomposed by hemoglobin (Hb) through the Fenton reaction in a temperature-dependent fashion. The mechanism underlying paliperidone decomposition involves the cleavage of its C–N bond linker moiety. The mass spectra obtained by liquid chromatography–quadrupole orbitrap mass spectrometry revealed the formation of 6-fluoro-3-(4-piperidinyl)benzisoxazole (PM1) in Hb/H2O2 solution incubated with paliperidone, as well as in the blood of individuals who died from intentional ingestion of paliperidone. These results suggest that PM1 is the only metabolite produced from paliperidone as a result of temperature-dependent, postmortem changes induced by Hb via the Fenton reaction and may be useful as a biomarker to correct for the concentration of paliperidone in blood at the time of death in clinical cases.